SMART 2D: Study of Montelukast's Effects on Renal and Cardiovascular Health in Adolescents and Young Adults With Type 2 Diabetes
Recruiting
Early Phase 1
Interventional Study
Type 2 Diabetes
At a Glance
- Age
- 14 – 24
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 50 (estimated)
- Sponsor
- University of Colorado, Denver · Other
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Adolescents and young adults (AYA) with type 2 diabetes (T2D) have a more severe phenotype than what is seen in youth-onset type 1 diabetes or adult-onset T2D including earlier kidney and cardiovascular disease complications; and prioritizing new treatments, either for standalone use or in combination with other therapies is critical. T2D triggers the release of proinflammatory mediators called cy…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 14-24 years
* Tanner stage \>2
* Diabetes onset \<18 years of age and \<10 years duration prior to study start
* HgbA1c \<10%
* Blood pressure \<130/80 mm Hg prior to randomization
* Stable anti-hypertensive regimen for at least one month prior to randomization
* BMI \< 40…
Contacts
No contact information available.